iTonic Holdings Ltd (ITOC): Revenue

Annual figures by period end, from SEC filings.

$523.0K
Year ended 2025-12-31
-8.4%
3-year compound annual growth
$679.8K2022-12-31: $679.8K2023-12-31: $628.6K2024-12-31: $448.2K2025-12-31: $523.0K$523.0K
2022-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$523.0K+16.7%2026-04-02, From 2025-01-01
2024-12-31$448.2K-28.7%2026-04-02, From 2024-01-01
2023-12-31$628.6K-7.5%2026-04-02, From 2023-01-01
2022-12-31$679.8Kn/a2025-03-20, From 2022-01-01

Revenue at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
iTonic Holdings Ltd (ITOC)2025-12-31$523.0K+16.7%
Positron Corp (POSC)2025-12-31$461.5K-21.5%
Guided Therapeutics Inc (GTHP)2025-12-31$767.0Kn/m
Nexalin Technology, Inc. (NXL)2025-12-31$301.6K+78.8%
Hongchang International Co., Ltd (HCIL)2024-12-31$2.87M+7.1%
ADM Tronics Unlimited, Inc. (ADMT)2026-03-31$3.35M+4.7%
Neuraxis, Inc (NRXS)2025-12-31$3.57M+32.9%
Nuwellis, Inc. (NUWE)2025-12-31$8.27M-5.4%
Escalon Medical Corp (ESMC)2026-06-30$12.74M+5.7%

Compare ITOC, POSC, GTHP, NXL side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗